Immunogen, Inc. (IMGN) Tops Q4 Expectations
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Financial Fact:
Research and development support: 1.35M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development support: 1.35M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Immunogen, Inc. (NASDAQ: IMGN) reported Q4 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $3.83 million versus the consensus estimate of $3.44 million.
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Radnostix revenue falls 27% amid product recalls and FDA actions
- Benchmark Reiterates Buy Rating on Jumia Technologies (JMIA)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
